Stephan Röver

986 total citations
15 papers, 615 citations indexed

About

Stephan Röver is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, Stephan Röver has authored 15 papers receiving a total of 615 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Cellular and Molecular Neuroscience and 5 papers in Organic Chemistry. Recurrent topics in Stephan Röver's work include Receptor Mechanisms and Signaling (6 papers), Neuropeptides and Animal Physiology (4 papers) and Cannabis and Cannabinoid Research (3 papers). Stephan Röver is often cited by papers focused on Receptor Mechanisms and Signaling (6 papers), Neuropeptides and Animal Physiology (4 papers) and Cannabis and Cannabinoid Research (3 papers). Stephan Röver collaborates with scholars based in Switzerland, United States and Germany. Stephan Röver's co-authors include Andrea M. Cesura, R. Kettler, Philipp Huguenin, Peter Wipf, Geo Adam, François Jenck, Jürgen Wichmann, Frank M. Dautzenberg, Frederick J. Monsma and Guido Galley and has published in prestigious journals such as FEBS Letters, Journal of Medicinal Chemistry and Tetrahedron Letters.

In The Last Decade

Stephan Röver

15 papers receiving 586 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stephan Röver Switzerland 13 297 206 168 167 108 15 615
R. Pellicciari Italy 17 341 1.1× 160 0.8× 155 0.9× 394 2.4× 249 2.3× 43 1.1k
Katarzyna M. Targowska‐Duda Poland 19 535 1.8× 236 1.1× 86 0.5× 81 0.5× 30 0.3× 56 820
Xiangqing Xu China 18 322 1.1× 173 0.8× 237 1.4× 100 0.6× 38 0.4× 40 685
Björn E. Svensson Sweden 11 204 0.7× 260 1.3× 87 0.5× 17 0.1× 77 0.7× 14 584
Alice Fialho Viana Brazil 17 172 0.6× 96 0.5× 68 0.4× 60 0.4× 55 0.5× 25 587
Senait Ghirmai United States 10 190 0.6× 124 0.6× 45 0.3× 40 0.2× 42 0.4× 14 607
Toshihito Kumagai Japan 10 170 0.6× 190 0.9× 85 0.5× 81 0.5× 150 1.4× 18 433
Ian M. Mawer United States 11 422 1.4× 295 1.4× 333 2.0× 33 0.2× 24 0.2× 12 771
Magdalena Kotańska Poland 15 271 0.9× 123 0.6× 137 0.8× 44 0.3× 28 0.3× 70 654
Carl Haslam United Kingdom 11 256 0.9× 133 0.6× 75 0.4× 57 0.3× 54 0.5× 15 539

Countries citing papers authored by Stephan Röver

Since Specialization
Citations

This map shows the geographic impact of Stephan Röver's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephan Röver with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephan Röver more than expected).

Fields of papers citing papers by Stephan Röver

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephan Röver. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephan Röver. The network helps show where Stephan Röver may publish in the future.

Co-authorship network of co-authors of Stephan Röver

This figure shows the co-authorship network connecting the top 25 collaborators of Stephan Röver. A scholar is included among the top collaborators of Stephan Röver based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephan Röver. Stephan Röver is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Nettekoven, Matthias, Jean‐Michel Adam, Stefanie Bendels, et al.. (2015). Novel Triazolopyrimidine‐Derived Cannabinoid Receptor 2 Agonists as Potential Treatment for Inflammatory Kidney Diseases. ChemMedChem. 11(2). 179–189. 42 indexed citations
2.
Nettekoven, Matthias, Jürgen Fingerle, Uwe Grether, et al.. (2013). Highly potent and selective cannabinoid receptor 2 agonists: Initial hit optimization of an adamantyl hit series identified from high-through-put screening. Bioorganic & Medicinal Chemistry Letters. 23(5). 1177–1181. 12 indexed citations
3.
Röver, Stephan, Mirjana Andjelković, Agnès Bénardeau, et al.. (2013). 6-Alkoxy-5-aryl-3-pyridinecarboxamides, a New Series of Bioavailable Cannabinoid Receptor Type 1 (CB1) Antagonists Including Peripherally Selective Compounds. Journal of Medicinal Chemistry. 56(24). 9874–9896. 24 indexed citations
4.
Peters, Jens‐Uwe, Henrietta Dehmlow, Uwe Grether, et al.. (2010). Pyrido pyrimidinones as selective agonists of the high affinity niacin receptor GPR109A: Optimization of in vitro activity. Bioorganic & Medicinal Chemistry Letters. 20(18). 5426–5430. 11 indexed citations
5.
Adams, David, Sven Taylor, Stephan Röver, et al.. (2004). 5-HT2C Receptor Agonists for the Treatment of Obesity. Biological and Chemical Adventures. CHIMIA International Journal for Chemistry. 58(9). 613–613. 18 indexed citations
6.
Kolczewski, Sabine, Geo Adam, Andrea M. Cesura, et al.. (2002). Novel Hexahydrospiro[piperidine-4,1‘-pyrrolo[3,4-c]pyrroles]:  Highly Selective Small-Molecule Nociceptin/Orphanin FQ Receptor Agonists. Journal of Medicinal Chemistry. 46(2). 255–264. 28 indexed citations
7.
Röver, Stephan, Jürgen Wichmann, François Jenck, Geo Adam, & Andrea M. Cesura. (2000). ORL1 receptor ligands: Structure–activity relationships of 8-cycloalkyl-1-phenyl-1,3,8-triaza-spiro[4.5]decan-4-ones. Bioorganic & Medicinal Chemistry Letters. 10(8). 831–834. 24 indexed citations
8.
Röver, Stephan, Geo Adam, Andrea M. Cesura, et al.. (2000). High-Affinity, Non-Peptide Agonists for the ORL1 (Orphanin FQ/Nociceptin) Receptor. Journal of Medicinal Chemistry. 43(7). 1329–1338. 68 indexed citations
9.
Wichmann, J., et al.. (1999). 8-Acenaphthen-1-yl-1-phenyl-1,3,8-triaza-spiro[4.5]decan-4-one derivatives as orphanin FQ receptor agonists. Bioorganic & Medicinal Chemistry Letters. 9(16). 2343–2348. 50 indexed citations
10.
Röver, Stephan & Peter Wipf. (1999). Synthesis and applications of fluorous silyl protecting groups with improved acid stability. Tetrahedron Letters. 40(31). 5667–5670. 52 indexed citations
11.
Cesura, Andrea M., et al.. (1997). Cloning and functional expression of human kynurenine 3‐monooxygenase. FEBS Letters. 410(2-3). 407–412. 40 indexed citations
12.
Röver, Stephan, et al.. (1997). Synthesis and Biochemical Evaluation ofN-(4-Phenylthiazol-2-yl)benzenesulfonamides as High-Affinity Inhibitors of Kynurenine 3-Hydroxylase. Journal of Medicinal Chemistry. 40(26). 4378–4385. 179 indexed citations
13.
Beutner, S., Karlis Briviba, Hans‐Dieter Martin, et al.. (1997). Singlet Oxygen Quenching Abilities of Carotenoids. Liebigs Annalen. 1997(9). 1887–1893. 43 indexed citations
14.
Kettler, R., et al.. (1995). Design and Synthesis of Novel and Potent Monoamine Oxidase Inhibitors. CHIMIA International Journal for Chemistry. 49(10). 381–381. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026